Markets市場

Shareholder rights firm calls GeneDx Holdings investors to lead WGS securities fraud class action

Securities fraud class actions have become a consistent feature of the broader biotech listing cycle, and GeneDx Holdings Corp. is now among those facing one. The Schall Law Firm, a nation

By Adaeze Nwosu·July 19, 2026·二〇二六年七月十九日·2 min read